KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petmed Express (PETS) Receivables (2016 - 2025)

Petmed Express has reported Receivables over the past 15 years, most recently at $1.6 million for Q4 2025.

  • For Q4 2025, Receivables fell 30.99% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, down 30.99%, while the annual FY2025 figure was $2.3 million, 29.42% down from the prior year.
  • Receivables for Q4 2025 was $1.6 million at Petmed Express, down from $2.0 million in the prior quarter.
  • Over five years, Receivables peaked at $3.3 million in Q1 2024 and troughed at $1.3 million in Q4 2021.
  • A 5-year average of $2.0 million and a median of $1.9 million in 2022 define the central range for Receivables.
  • Biggest five-year swings in Receivables: crashed 32.68% in 2021 and later skyrocketed 88.68% in 2024.
  • Year by year, Receivables stood at $1.3 million in 2021, then soared by 53.43% to $1.9 million in 2022, then dropped by 0.72% to $1.9 million in 2023, then grew by 17.05% to $2.3 million in 2024, then crashed by 30.99% to $1.6 million in 2025.
  • Business Quant data shows Receivables for PETS at $1.6 million in Q4 2025, $2.0 million in Q3 2025, and $1.6 million in Q2 2025.